Trial
NCT01720043
Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
—
Condition
Multiple Myeloma
Intervention
Velcade
Why stopped
Slow Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-05